David J Grainger - Net Worth and Insider Trading
David J Grainger Net Worth
The estimated net worth of David J Grainger is at least $8 Million dollars as of 2024-05-24. David J Grainger is the Chief Innovation Officer of Centessa Pharmaceuticals PLC and owns about 936,075 shares of Centessa Pharmaceuticals PLC (CNTA) stock worth over $8 Million. Details can be seen in David J Grainger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David J Grainger has not made any transactions after 2022-10-03 and currently still holds the listed stock(s).
Transaction Summary of David J Grainger
David J Grainger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David J Grainger owns 1 companies in total, including Centessa Pharmaceuticals PLC (CNTA) .
Click here to see the complete history of David J Grainger’s form 4 insider trades.
Insider Ownership Summary of David J Grainger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2022-10-03 | Chief Innovation Officer |
David J Grainger Latest Holdings Summary
David J Grainger currently owns a total of 1 stock. David J Grainger owns 936,075 shares of Centessa Pharmaceuticals PLC (CNTA) as of October 3, 2022, with a value of $8 Million.
Latest Holdings of David J Grainger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2022-10-03 | 936,075 | 8.35 | 7,816,226 |
Holding Weightings of David J Grainger
David J Grainger Form 4 Trading Tracker
According to the SEC Form 4 filings, David J Grainger has made a total of 2 transactions in Centessa Pharmaceuticals PLC (CNTA) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Centessa Pharmaceuticals PLC is the sale of 5,181 shares on October 3, 2022, which brought David J Grainger around $20,724.
Insider Trading History of David J Grainger
- 1
David J Grainger Trading Performance
GuruFocus tracks the stock performance after each of David J Grainger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David J Grainger is -5.04%. GuruFocus also compares David J Grainger's trading performance to market benchmark return within the same time period. The performance of stocks bought by David J Grainger within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David J Grainger's insider trading performs compared to the benchmark.
Performance of David J Grainger
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.29 | | | | | |
| Relative Return to S&P 500(%) | -2.98 | | | | | |
David J Grainger Ownership Network
David J Grainger Owned Company Details
What does Centessa Pharmaceuticals PLC do?
Who are the key executives at Centessa Pharmaceuticals PLC?
David J Grainger is the Chief Innovation Officer of Centessa Pharmaceuticals PLC. Other key executives at Centessa Pharmaceuticals PLC include Chief People Officer Karen M. Anderson , SVP Regulatory Affairs Harris Rotman , and Chief Medical Officer Antoine Yver .
Centessa Pharmaceuticals PLC (CNTA) Insider Trades Summary
Over the past 18 months, David J Grainger made no insider transaction in Centessa Pharmaceuticals PLC (CNTA). Other recent insider transactions involving Centessa Pharmaceuticals PLC (CNTA) include a net sale of 44,370 shares made by Antoine Yver , a net sale of 41,751 shares made by Harris Rotman , and a net sale of 51,160 shares made by Karen M. Anderson .
In summary, during the past 3 months, insiders sold 51,160 shares of Centessa Pharmaceuticals PLC (CNTA) in total and bought 0 shares, with a net sale of 51,160 shares. During the past 18 months, 145,281 shares of Centessa Pharmaceuticals PLC (CNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 145,281 shares.
Centessa Pharmaceuticals PLC (CNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Centessa Pharmaceuticals PLC Insider Transactions
David J Grainger Mailing Address
Above is the net worth, insider trading, and ownership report for David J Grainger. You might contact David J Grainger via mailing address: C/o Centessa Pharmaceuticals Plc, 3rd Fl., 1 Ashley Rd, Altrincham, Cheshire X0 Wa14 2dt.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
